Chromosome 5: Its Functions and Associated Conditions

Chromosome 5 is one of the largest human chromosomes, spanning about 178 million base pairs, yet it carries a surprisingly low density of protein-coding genes compared to its size. Despite housing only around 923 known protein-coding genes, these genes punch well above their weight: they include clusters that wire neurons in the developing brain, orchestrate immune responses, and guard against uncontrolled cell growth. When parts of chromosome 5 are deleted, duplicated, or mutated, the consequences range from rare childhood syndromes to common inflammatory diseases and several forms of cancer.

Size, Structure, and a Paradox

The complete sequence of chromosome 5, published in 2004, revealed something unexpected. While the chromosome is physically large, much of its DNA does not code for proteins. Instead, large stretches are occupied by noncoding sequences that are remarkably similar across vertebrates, from humans down to fish. That kind of evolutionary conservation across hundreds of millions of years strongly suggests these regions do something important, even though researchers are still working out exactly what. The chromosome also contains many internal duplications, regions where chunks of DNA have been copied and pasted at different locations along its length, which can predispose it to structural rearrangements during cell division.¹

What chromosome 5 lacks in sheer gene count, it makes up for in functional variety. Its genes fall into several distinct clusters, each responsible for a different biological system. Two of the most studied are the protocadherin cluster, which is central to brain development, and the cytokine gene cluster on the long arm (5q), which plays a major role in immune regulation. Mutations in individual genes scattered across chromosome 5 also cause well-known conditions like spinal muscular atrophy, Treacher Collins syndrome, and familial adenomatous polyposis.

The Protocadherin Cluster and Brain Wiring

One of chromosome 5’s most remarkable features is its cluster of protocadherin genes. These genes encode cell-surface proteins that act as molecular identity tags on neurons. Each neuron switches on a different combination of protocadherins, creating a unique barcode that allows it to distinguish itself from its neighbors. This self-recognition system prevents a neuron’s own branches from tangling with each other while still allowing it to form proper connections with other cells.²

The process matters enormously during brain development. Protocadherins guide neuron migration, help dendrites spread out evenly, prevent axons from bundling incorrectly, and influence how synapses form.³ Because the system relies on combinatorial diversity, where each neuron expresses a slightly different set of these proteins, the protocadherin cluster generates an enormous number of possible identity codes from a relatively compact stretch of DNA.⁴

When protocadherin genes are disrupted, the consequences can be severe. Research increasingly links mutations in this cluster to susceptibility for several mental disorders, though the precise relationships are still being mapped. The idea is straightforward: if neurons cannot tell themselves apart from their neighbors, the resulting circuits get miswired, and miswired circuits can manifest as psychiatric or neurodevelopmental conditions.³

The Cytokine Gene Cluster and Immune Regulation

The long arm of chromosome 5, particularly the region labeled 5q31, is densely packed with genes that regulate the immune system. Among the most prominent are the genes for interleukin-4 (IL-4) and interleukin-13 (IL-13), two signaling molecules that sit just 12.5 kilobases apart and are often switched on together in T cells. Their close physical arrangement is not a coincidence: the two genes share regulatory elements and are activated in a coordinated fashion, especially in T cells that have been previously primed by an immune encounter.⁵

Nearby on the same stretch of DNA sit the genes for IL-3, IL-5, and GM-CSF, three cytokines that are critical for eosinophil development. Eosinophils are white blood cells involved in fighting parasites and driving allergic inflammation. Mutations or overactivity in this region can lead to familial eosinophilia, a heritable condition in which eosinophil counts are persistently elevated.⁶

This dense immune-gene neighborhood makes the 5q31 region a hotspot for research into common inflammatory conditions, particularly asthma and Crohn’s disease.

Asthma, Allergies, and Crohn’s Disease

Because so many immune-signaling genes sit on chromosome 5q, genetic variation in this region has been linked to susceptibility for asthma and atopic (allergy-prone) conditions. Studies across multiple populations have found that variants in the IL-4 gene are associated with asthma, while variants in the IL-13 gene are strongly associated with elevated IgE levels and sensitivity to mold allergens.⁷ Earlier work on both chromosome 5q and chromosome 11 identified the IL-4 gene cluster as a candidate region for genes relevant to bronchial hyperresponsiveness.⁸

Crohn’s disease, a chronic inflammatory condition of the gut, has a different but overlapping genetic story on chromosome 5. A roughly 250-kilobase stretch on 5q31, sometimes called the IBD5 locus, carries a risk haplotype that has been consistently associated with Crohn’s disease across multiple populations.⁹ Pinning down which specific gene in the region drives the risk has been tricky. One candidate is a variant in SLC22A4, a transporter gene, though its effect seems to depend on the broader haplotype context rather than acting alone. Other associated variants sit in immune-regulatory genes like IRF1 and RAD50 that lie just outside the core risk haplotype.¹⁰

Cri du Chat Syndrome

The best-known structural abnormality on chromosome 5 is a deletion on its short arm (5p), which causes Cri du Chat syndrome. The name, French for “cry of the cat,” comes from the distinctive high-pitched cry that affected infants produce, a result of abnormal laryngeal development. Beyond the characteristic cry, the condition involves intellectual disability, delayed development, a small head, and distinctive facial features.¹¹

The deletion varies in size from patient to patient. Larger deletions that exceed about 10 million base pairs can be detected on a standard karyotype, while smaller ones require more sensitive testing methods.¹² A recent rat model engineered with CRISPR to carry a deletion in the corresponding chromosomal region has helped illuminate the condition’s biology, revealing inflammatory and immune disruptions alongside the expected neurological deficits.¹³ Effective treatments remain limited, and current management focuses on supportive therapies, though early intervention programs for speech and motor development can substantially improve quality of life.

Sotos Syndrome and Treacher Collins Syndrome

On the opposite end of chromosome 5, at 5q35, sits the NSD1 gene. Mutations or deletions in NSD1 cause Sotos syndrome, a condition characterized by overgrowth, distinctive facial features, and learning difficulties. In a review of 239 individuals with confirmed NSD1 mutations, facial features and learning disability were present in about 90% of cases. However, roughly one in ten had height and head size within the normal range, meaning overgrowth is a common feature but not an absolute requirement for the diagnosis.¹⁴ Some cases are caused by point mutations in the gene, while others result from large deletions that remove the NSD1 region entirely.¹⁵

Treacher Collins syndrome is another craniofacial condition tied to chromosome 5. It results from mutations in the TCOF1 gene, which produces a protein called treacle that is essential for ribosome production in rapidly dividing cells during early embryonic development. When treacle is insufficient, the neural crest cells that give rise to facial bones and cartilage undergo excessive programmed cell death, leading to underdeveloped cheekbones, a small jaw, and malformed ears.¹⁶ Research has confirmed that treacle interacts directly with the machinery responsible for ribosomal RNA production, and that insufficient ribosomal RNA triggers a stress response that kills developing cells at a critical window in embryogenesis.¹⁷

Spinal Muscular Atrophy

Spinal muscular atrophy (SMA) is one of the most consequential single-gene diseases mapped to chromosome 5. It results from loss of function of the SMN1 gene at 5q13, usually through homozygous deletion of a critical segment called exon 7. Without a working SMN1 gene, motor neurons in the spinal cord degenerate, leading to progressive muscle weakness and, in severe forms, respiratory failure.¹⁸

The genetics of SMA are unusually nuanced because of a nearly identical backup gene called SMN2 that sits nearby on the same chromosome. SMN2 produces mostly a shortened, unstable form of the protein, but it does make a small amount of functional protein. The number of SMN2 copies a patient carries is the single strongest predictor of disease severity: more copies mean more functional protein and milder symptoms. In a minority of patients, instead of a straightforward deletion, a gene-conversion event occurs in which part of SMN1 gets replaced by the corresponding part of SMN2, effectively silencing the gene without physically removing it.¹⁹

SMA has become a showcase for precision gene therapy. The drug nusinersen is an antisense oligonucleotide that coaxes the SMN2 gene into including exon 7 in more of its protein products, effectively boosting the amount of functional protein. A more direct approach, onasemnogene abeparvovec (marketed as Zolgensma), uses a viral vector to deliver a complete working copy of the SMN1 gene into motor neurons.²⁰ The availability of newborn screening for SMA in many countries now means treatment can begin before symptoms appear, which dramatically improves outcomes.

Tay-Sachs Disease

The HEXA gene on chromosome 5 encodes a subunit of an enzyme that breaks down a fatty substance called GM2 ganglioside inside cells. When HEXA is mutated, the enzyme cannot function properly, and GM2 ganglioside accumulates in nerve cells, destroying them progressively. This is Tay-Sachs disease, a condition most commonly known in its infantile form, which typically leads to severe neurological decline within the first few years of life. Researchers have cataloged a wide variety of HEXA mutations, including deletions, splice-site changes, and missense mutations at multiple positions along the gene.²¹

At the molecular level, many Tay-Sachs mutations cause the defective enzyme subunit to be flagged for destruction before it ever reaches its intended destination within the cell. The cell’s quality-control machinery recognizes that the protein has folded incorrectly and routes it to the proteasome for degradation, a process that effectively eliminates whatever residual enzyme activity the mutant protein might have had.²² Carrier screening programs, particularly within populations where certain HEXA mutations are more common, have dramatically reduced the incidence of Tay-Sachs in recent decades.

Cancer Connections on Chromosome 5

Several cancer-related genes reside on chromosome 5, and deletions of portions of the chromosome are recurrent events in certain malignancies. One of the best characterized is the APC gene at 5q21-22. Inherited mutations in APC cause familial adenomatous polyposis (FAP), a condition in which hundreds to thousands of polyps develop in the colon, virtually guaranteeing colorectal cancer if left untreated.²³ The gene was originally mapped to chromosome 5 after researchers noticed a patient with a visible deletion in the 5q region who had both developmental abnormalities and FAP.²⁴

In blood cancers, deletion of part of the long arm of chromosome 5 defines a specific subtype of myelodysplastic syndrome (MDS) known as the 5q- syndrome. The hallmark is a severe anemia with characteristically large red blood cells. Research identified the gene RPS14, which encodes a ribosomal protein, as the key driver. Losing one copy of RPS14 disrupts the processing of ribosomal RNA in red blood cell precursors, triggering a stress response that kills them off before they mature.²⁵ The connection between ribosomal protein deficiency and anemia mirrors what is seen in Diamond-Blackfan anemia, a congenital bone marrow failure syndrome, linking these two conditions at a molecular level.²⁶

Another gene on chromosome 5, MSH3, is involved in DNA mismatch repair. A common variant in MSH3 (rs26279) has been associated with a modestly increased risk of cancer overall, with the strongest associations seen for colorectal and breast cancer across multiple populations.²⁷ The same gene also influences how cancer cells respond to certain chemotherapy drugs, making it potentially relevant for treatment decisions.²⁸

At the tip of the short arm, chromosome 5p15.33 harbors the TERT gene, which encodes the catalytic component of telomerase, the enzyme that maintains the protective caps on the ends of chromosomes. Genome-wide association studies across both European and Asian populations have consistently identified variants in TERT and the neighboring CLPTM1L gene as risk factors for lung cancer.²⁹ Fine-mapping studies in Han Chinese populations have confirmed specific TERT variants with increased lung cancer odds.³⁰

Targeted Treatments Emerging from Chromosome 5 Biology

The detailed understanding of which genes are lost in 5q deletions has enabled remarkably targeted therapies. The clearest success story is lenalidomide for the 5q- syndrome form of MDS. The drug works by promoting the degradation of a protein called CK1α, which is encoded by a gene within the commonly deleted region. Because patients with del(5q) already have only one working copy of the CK1α gene, their cells produce less of the protein to begin with and are therefore more sensitive to lenalidomide-induced degradation than normal cells. This selective vulnerability is what creates the therapeutic window: cancer cells with the deletion are hit harder than healthy cells.³¹ Lenalidomide also pushes del(5q) cells toward differentiation into megakaryocytes, which then undergo cell death, further reducing the malignant population.³²

Resistance to lenalidomide does develop in some patients, and outcomes differ depending on the broader genetic context. Acute myeloid leukemia with an isolated 5q deletion tends to carry IDH1 or IDH2 mutations and has longer overall survival than cases where the 5q deletion is part of a complex karyotype with multiple chromosomal abnormalities.³³

TERT and the Telomere Frontier

The TERT gene’s dual role in both cancer susceptibility and aging has made it a fascinating target for experimental gene therapy. Telomerase is the enzyme that lengthens telomeres, the protective end-caps on chromosomes that shorten each time a cell divides. In cancer, telomerase is often overactive, allowing tumor cells to divide indefinitely. But in aging, telomere shortening contributes to tissue decline, and researchers have explored whether carefully controlled telomerase activation might slow that process.

In mouse studies, delivering the TERT gene via a viral vector to one- and two-year-old mice improved insulin sensitivity, bone density, and neuromuscular coordination. Median lifespan increased by 24% in the younger group and 13% in the older group. Critically, the treated mice did not develop more tumors than untreated controls, suggesting that the cancer-promoting effects of telomerase are blunted when the gene is introduced into adult or aged organisms rather than during the rapid growth phases of early life.³⁴ Whether these results translate to humans remains to be seen. The challenge is inherently paradoxical: any therapy that boosts telomerase to combat aging must somehow avoid giving cancer cells the same longevity advantage.³⁵ For now, this work remains firmly in the realm of animal research, but chromosome 5’s TERT gene sits squarely at the center of it.